ClinicalTrials.gov
public full text
Public Domain
An Evaluation of LY007 Cell Injection for r/r B-NHL
An evaluation of LY007 cell injection for recurrent/refractory CD20 was positive Tolerability, safety, and efficacy of B-cell non-Hodgkin lymphoma in open, single-arm Phsea I Clinical research
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Evaluation of LY007 Cell Injection for r/r B-NHL#802246
- RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas#1086975
- RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas#968074
- GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma#979627
- A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours#870777
Record · ID 885022
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive